Search Results - I. I. Andreyashkina

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    The ICEDORA study: clinical and demographic characteristics and treatment regimens of patients with HR+ HER2- locally advanced or metastatic breast cancer receiving CDK4/6 inhibitors in real clinical practice

    The ICEDORA study: clinical and demographic characteristics and treatment regimens of patients with HR+ HER2- locally advanced or metastatic breast cancer receiving CDK4/6 inhibito... by I. E. Khatkov, I. I. Andreyashkina, I. D. Trotsenko, O. N. Matveeva, V. A. Reznikov

    Published 2025-07-01
    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    Effectiveness of cyclin-dependent kinase 4 and 6 inhibitors for the treatment of hormonesensitive HER2-negative metastatic breast cancer in first-line therapy: A systematic literature review

    Effectiveness of cyclin-dependent kinase 4 and 6 inhibitors for the treatment of hormonesensitive HER2-negative metastatic breast cancer in first-line therapy: A systematic literat... by N. A. Avxentyev, I. I. Andreyashkina, E. V. Artamonova, L. V. Bolotina, E. I. Kovalenko, N. N. Sisigina

    Published 2024-05-01
    Get full text
    Article

    Save to List
    Saved in:

Search Tools: